Oncocyte Reports First Quarter 2024 Financial Results
15 mai 2024 16h05 HE
|
OncoCyte Corporation
ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Oncocyte to Announce First Quarter 2024 Financial Results
13 mai 2024 08h00 HE
|
OncoCyte Corporation
Oncocyte to Announce First Quarter 2024 Financial Results
Oncocyte Reports Full Year 2023 Financial Results
12 avr. 2024 06h00 HE
|
OncoCyte Corporation
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
11 avr. 2024 21h46 HE
|
OncoCyte Corporation
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
11 avr. 2024 17h30 HE
|
OncoCyte Corporation
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
09 avr. 2024 16h05 HE
|
OncoCyte Corporation
ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
16 janv. 2024 08h00 HE
|
OncoCyte Corporation
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
15 déc. 2020 01h33 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into an exclusive licensing agreement...
OncoCyte Presents Positive Data from its Liquid Biopsy Breast Cancer Diagnostic Test at the San Antonio Breast Cancer Symposium
07 déc. 2017 08h30 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, today presented...
California Life Sciences Association (CLSA) Adds Leaders from Genentech, Sanford Burnham Prebys Medical Discovery Institute and OncoCyte to Board of Directors
23 nov. 2015 08h06 HE
|
California Life Sciences Association
SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 23, 2015 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA), today announced that its board of directors appointed three new members: William...